Inflammation in rheumatology in 2015: New tools to tackle inflammatory arthritis

Nat Rev Rheumatol. 2016 Feb;12(2):78-80. doi: 10.1038/nrrheum.2015.180. Epub 2016 Jan 14.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Gouty / drug therapy*
  • Arthritis, Gouty / immunology
  • Caspase Inhibitors / therapeutic use
  • Evidence-Based Medicine
  • Humans
  • Inflammation / drug therapy
  • Randomized Controlled Trials as Topic
  • Rheumatology* / trends
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • alpha 1-Antitrypsin / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Caspase Inhibitors
  • Tumor Necrosis Factor-alpha
  • alpha 1-Antitrypsin
  • canakinumab
  • brodalumab
  • secukinumab